12.77
price down icon3.04%   -0.40
after-market 시간 외 거래: 13.02 0.25 +1.96%
loading

Trevi Therapeutics Inc (TRVI) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
19.63%
13.72
11.47 12.24 14.09 13.29
Operating Income/Loss
19.63%
-13.72
-11.47 -12.24 -14.09 -13.29
Nonoperating Income/Loss
25.11%
1.40
1.119 0.844 0.814 0.929
Income/Loss From Continuing Operations Before Tax
19.04%
-12.32
-10.35 -11.40 -13.27 -12.36
Income Tax Expense/Benefit
90.91%
-0.021
-0.011 0.016 -0.031 -0.008
Income/Loss From Continuing Operations After Tax
18.97%
-12.30
-10.34 -11.41 -13.24 -12.35
Net Income/Loss
18.97%
-12.30
-10.34 -11.41 -13.24 -12.35
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
10.83%
130.35
117.61 1.3558 101.28 101.04
Diluted Average Shares
10.83%
130.35
117.61 1.3558 101.28 101.04
Basic Earnings Per Share
0.00%
-0.09
-0.09 -0.11 -0.13 -0.12
Diluted Earnings Per Share
0.00%
-0.09
-0.09 -0.11 -0.13 -0.12
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
자본화:     |  볼륨(24시간):